BMRN PDUFA Date: VOXZOGO Page updated November 5, 2026 · next FDA decision on the calendar · Data as of Nov 14, 2026 7:42 PM ET FDA decision (PDUFA) target May 30, 2027 · Biomarin Pharmaceutical Inc · Hypochondroplasia
Also under FDA review from Biomarin Pharmaceutical Inc, as a separate application: VOXZOGO, Feb 28, 2027 . One application, one page; this page is the application with the May 30, 2027 goal date.
Key facts FDA PDUFA target date 2027-05-30
Drug / candidate VOXZOGO (vosoritide)
Indication Hypochondroplasia
Company Biomarin Pharmaceutical Inc
Market-cap tier Large
New to FDA decisions? Read what a PDUFA date is and how often the FDA approves drugs .
See every 2027 PDUFA date → All May 2027 PDUFA dates → FAQ When is the BMRN PDUFA date? The FDA PDUFA target date for BMRN (Biomarin Pharmaceutical Inc) is 2027-05-30 for VOXZOGO (vosoritide). Dates are company/FDA-sourced and can slip. Verify against primary filings.
What is BMRN's drug VOXZOGO? VOXZOGO (vosoritide) is Biomarin Pharmaceutical Inc's candidate under FDA review for Hypochondroplasia.
Other upcoming FDA decisions: BBIO 2027-05-08: Encaleret · BMY 2027-05-13: Mezigdomide + carfilzomib + dexamethasone · ZBIO 2027-05-27: Obexelimab · URGN 2027-06-14: UGN-103 (mitomycin) · MRK 2027-06-15: Sacituzumab tirumotecan (sac-TMT) · COGT 2027-06-29: Bezuclastinib · All May 2027 PDUFA dates · BMRN catalyst hub Browse pdufa.bio: FDA calendar 2026 · 2027 PDUFA dates · FDA decisions today · This week · This month · Decisions 2026 · Decisions 2025 · CRL database · FDA approvals by month · FDA approval letters · Decision timing study · Run-up study · FDA approval rate · Oncology readouts · Readouts · Conferences · Corrections · All pages Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes. © 2026 pdufa.bio. All rights reserved.